BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16917214)

  • 1. High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice.
    Decaudin D; Marszak FB; Couturier J; Mathiot C; Martin A; Némati F; Lantz O; Santo Jd; Arnaud P; Bordier V; Vincent-Salomon A; Poupon MF
    Anticancer Drugs; 2006 Jul; 17(6):685-95. PubMed ID: 16917214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus (EBV)-associated lymphoproliferations in severe combined immunodeficient mice transplanted with Hodgkin's disease lymph nodes: implications of EBV-positive bystander B lymphocytes rather than EBV-infected Reed-Sternberg cells.
    Meggetto F; Muller C; Henry S; Selves J; Mariamé B; Brousset P; Saati TA; Delsol G
    Blood; 1996 Mar; 87(6):2435-42. PubMed ID: 8630408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib mesylate reduces rituximab-induced tumor-growth inhibition in vivo on Epstein-Barr virus-associated human B-cell lymphoma.
    Némati F; Mathiot C; Grandjean I; Lantz O; Bordier V; Dewulf S; Ekue R; Di Santo JP; Poupon MF; Decaudin D
    Anticancer Drugs; 2007 Oct; 18(9):1029-37. PubMed ID: 17704653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.
    Quintanilla-Martinez L; Fend F; Moguel LR; Spilove L; Beaty MW; Kingma DW; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Oct; 23(10):1233-40. PubMed ID: 10524524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly and Epstein-Barr virus-positive classical Hodgkin lymphoma.
    Hwang YY; Leung AY; Lau WH; Loong F; So JC; Tse E; Kwong YL
    Histopathology; 2011 Aug; 59(2):352-5. PubMed ID: 21884219
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice.
    Smith MR; Joshi I; Jin F; Obasaju C
    BMC Cancer; 2005 Aug; 5():103. PubMed ID: 16109167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas.
    Feng WH; Hong G; Delecluse HJ; Kenney SC
    J Virol; 2004 Feb; 78(4):1893-902. PubMed ID: 14747554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-induced transformation of cutaneous plasmacytoma into CD30+ diffuse large B-cell lymphoma.
    Donner LR
    Am J Dermatopathol; 2004 Feb; 26(1):63-6. PubMed ID: 14726824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone: report of two cases from South America.
    Beltran BE; Castillo JJ; Salas R; Quiñones P; Morales D; Cotrina E; Miranda RN; Sotomayor EM
    Leuk Lymphoma; 2011 Jan; 52(1):153-6. PubMed ID: 21219127
    [No Abstract]   [Full Text] [Related]  

  • 12. Epstein-Barr virus-associated lymphoma in a child undergoing an autologous stem cell rescue.
    Heath JA; Broxson EH; Dole MG; Filippa DA; George D; Lyden D; Dunkel IJ
    J Pediatr Hematol Oncol; 2002 Feb; 24(2):160-3. PubMed ID: 11998794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells.
    Parrens M; Vergier B; Fitoussi O; Lahet C; Belleannee G; Marit G; Dubus P; de Mascarel A; Delfau-Larue MH; Merlio JP
    Am J Surg Pathol; 2002 Dec; 26(12):1634-42. PubMed ID: 12459631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
    Yang QX; Pei XJ; Tian XY; Li Y; Li Z
    Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma.
    Kamper P; Bendix K; Hamilton-Dutoit S; Honoré B; Nyengaard JR; d'Amore F
    Haematologica; 2011 Feb; 96(2):269-76. PubMed ID: 21071500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma.
    Yoshino T; Nakamura S; Matsuno Y; Ochiai A; Yokoi T; Kitadai Y; Suzumiya J; Tobinai K; Kobayashi Y; Oda I; Mera K; Ohtsu A; Ishikura S
    Cancer Sci; 2006 Feb; 97(2):163-6. PubMed ID: 16441428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of Epstein-Barr virus infection in head and neck non-Hodgkin's lymphomas in Khorasan, northeast of Iran.
    Abadi RZ; Sistani NS; Mohtasham N; Hesari KK; Vaezi T; Pazouki M; Shakeri MT
    J Pak Med Assoc; 2013 Jul; 63(7):882-7. PubMed ID: 23901714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
    Ueda K; Ikeda K; Ogawa K; Sukegawa M; Sano T; Kimura S; Suzuki O; Hashimoto Y; Takeishi Y
    J Med Case Rep; 2016 Aug; 10(1):236. PubMed ID: 27557810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.